What Magnolia Market Access does

Magnolia Market Access is a boutique healthcare consulting practice operating as a subsidiary within the Medical Knowledge Group (MKG) family of companies, founded in 2022 and headquartered in Bridgewater, New Jersey (legal entity domiciled in New York). The firm delivers market access and Health Economics and Outcomes Research (HEOR) services to biopharmaceutical and medical device manufacturers, trade associations, specialty societies, advocacy organizations, health plans and PBMs, and hospitals and health systems. Its service portfolio spans four practice areas: Policy & Access (including health policy, reimbursement, coding, and patient support services), Pricing & Value (pricing models, contracting, gross-to-net, payer strategy, AMCP dossiers), RWE & HEOR (study design, budget impact, cost-effectiveness, indirect treatment comparisons), and Commercialization & Analytics (launch planning, payer mix, site of care, market geo-mapping, distribution).

The firm's underlying technology is anchored by proprietary data assets — a Data Atlas and the Magnolia DRIVE repository containing Medicare claims (5% sample of 100% of beneficiaries), 305M+ all-payer open claims, 85M+ privately insured closed claims, 120M+ EHR patient records with full claims history, and 120M+ adult patients' SDOH data including race, SES, and consumer habits. These assets are HIPAA-compliant and linkable to external sources via tokenization. Supporting tools include the MAIN payer advisory network and the PAP 2.0 patient support program forecasting model. Magnolia also layers AI-enabled synthesis of payer intelligence across coverage patterns, value materials, and policy reports.

Magnolia generates revenue through professional services engagements sold via direct, consultative enterprise sales. Pricing is quote-based and not publicly disclosed. The GTM motion is relationship-driven and boutique, with Magnolia leveraging MKG's broader AI, HEOR research, and medical communications resources while serving clients from early pipeline development through patent expiration. The firm markets through monthly educational webinars, an insights blog (81+ articles), market access briefs, and participation in industry conferences such as ISPOR and Asembia AXS Summit.

Name

Magnolia Market Access

Legal name

Magnolia Market Access, LLC

Website

https://magnoliamarketaccess.com

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

11–50 employees

Short description

Magnolia Market Access is a boutique healthcare consulting firm specializing in market access and HEOR services for biopharmaceutical and medical device manufacturers, trade associations, and health plans, backed by the Medical Knowledge Group and proprietary real-world data assets.

Ownership category

akta.pro rank

Product category

Healthcare Market Access Consulting

NAICS

Professional, Scientific, and Technical Services (54), Marketing Consulting Services (541613), Marketing Research and Public Opinion Polling (541910)

SIC

Services-Management Consulting Services (8742), Services-Health Services (8000)

akta.pro primary industry

Market Research & Consumer Insights (BPAHALAA)

Keywords

• Market access consulting
• Health economics outcomes research
• Real-world evidence
• Healthcare policy analysis
• Pharmaceutical commercialization strategy

Headquarters

HQ city

Bridgewater

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

1. Market Access Consulting Services: Magnolia generates revenue through consulting engagements providing tailored market access strategy, healthcare policy analysis, pricing and value consulting, real-world evidence and HEOR services, and commercialization support to pharmaceutical and medical device manufacturers. Services are delivered across multiple practice areas including policy & access, pricing & value, RWE & HEOR, and commercialization & analytics.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

Magnolia Market Access is a boutique healthcare consulting practice providing market access strategy and Health Economics and Outcomes Research (HEOR) services to biopharmaceutical and medical device manufacturers. It delivers policy analysis, pricing and value consulting, real-world evidence generation, and commercialization support, backed by proprietary claims and EHR data assets.

Product overview

Magnolia Market Access is a boutique consulting practice within the Medical Knowledge Group family of companies, offering tailored healthcare product access solutions through multiple service streams. The core portfolio includes Policy & Access consulting, Pricing & Value Consulting, RWE & HEOR services, and Commercialization & Analytics—supported by proprietary data platforms including Magnolia DRIVE (containing Medicare claims, closed/open claims, EHR, and SDOH data) and the MAIN stakeholder network. Additional analytical tools include the PAP 2.0 patient assistance program forecasting model. The company integrates advanced AI technology for payer intelligence synthesis while leveraging their extensive real-world data assets to deliver comprehensive market access strategy from clinical development through market launch and beyond.

Differentiator

Problem solved

Functional benefit

Brands

• Magnolia DRIVE: Data Repository for Innovation and Value Evidence - an in-house data solution for market access and HEOR analytics.
• MAIN
• PAP 2.0

Products and services

• Policy & Access Comprehensive healthcare policy consulting encompassing health policy analysis, reimbursement strategy, coding applications (HCPCS, NTAP, ICD-10), patient support services design, and regulatory monitoring to support federal and state policy navigation for pharmaceutical and medical device manufacturers.
• Pricing & Value Consulting Strategic pricing and contracting consulting including pricing models, fair-market value assessments, rebate strategy, gross-to-net modeling, payer segmentation, compendia strategy, and development of AMCP dossiers and payer value propositions.
• RWE & HEOR (Real World Evidence & Health Economics and Outcomes Research) Real-world evidence generation and health economics research services including study design, budget impact modeling, cost-effectiveness analysis, indirect treatment comparisons, and evidence strategy aligned to payer and HTA decision-making.
• Commercialization & Analytics End-to-end drug commercialization services covering launch planning, competitive landscape assessment, payer mix analysis, site of care analysis, market geo-mapping, distribution strategy, and regulatory strategy consulting.
• Magnolia DRIVE (Data Repository for Innovation and Value Evidence) In-house proprietary data repository containing Medicare claims (5% sample, 100% of beneficiaries), closed claims (85M+ patients), open claims (305M+ patients), electronic health records (120M+ total patients), and social determinants of health data. Supports BYOD (Bring Your Own Data) policy for clients with existing data assets.
• MAIN (Market Access Insights Network) Expert stakeholder network connecting biopharma and device manufacturer clients with active US payers, managed care decision makers, actuaries, market access thought leaders, hospital administrators, and finance teams for strategic insights through interviews, surveys, advisory boards, and focus groups.
• PAP 2.0 Model (Patient Assistance Program 2.0) Configurable forecasting and scenario tool for patient support programs that enables manufacturers to assess how program design choices (copay maximums, PAP eligibility, bridge duration) and external factors impact utilization, affordability, and total program cost over time.

Quantifiable outcome

• 55% potential reduction in novel drug approvals over two decades due to combined policy pressures (hypothetical scenario analysis)

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature4 records

Partnerships

One partnership is on record.

• Medical Knowledge Group (MKG)coreStrategic or Co-development PartnerMagnolia Market Access is proud to be part of MKG—a collation of specialized companies offering advanced AI technology, comprehensive HEOR market research, and cutting-edge medical communications strategies. The Medical Knowledge Group umbrella provides Magnolia with access to virtually unlimited resources while maintaining its boutique consulting approach.

Scale indicators4 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Avalere Health: Healthcare policy, market access, and evidence-based consulting firm serving biopharma, payers, and providers. Closely overlaps Magnolia's Policy & Access and HEOR practices and frequently competes for federal/state policy and reimbursement engagements.
• PRECISIONscientia (Precision Value & Health): HEOR, market access, and medical communications consultancy under Precision Medicine Group. Overlaps directly with Magnolia's evidence generation, pricing, and payer value proposition practices.
• Beghou Consulting: Specialty life sciences consulting firm focused on commercial, market access, and advanced analytics for biopharma. Highly comparable boutique-style competitor serving similar manufacturer clients.
• PharmaLex (Cencora): Regulatory, market access, and HEOR consulting firm under Cencora (formerly AmerisourceBergen). Strong direct overlap with Magnolia in pricing, reimbursement, and evidence strategy for biopharma launches.
• Putnam Associates: Strategy consulting firm focused on biopharma commercialization, pricing, and market access. Direct competitor for pricing strategy, market access planning, and launch support engagements.
• Trinity Life Sciences: Life sciences strategy and evidence consultancy offering HEOR, market access, pricing, and commercial strategy. Direct competitor for payer strategy, value communications, and real-world evidence work.
• Xcenda (part of EVERSANA): Dedicated market access, HEOR, and health economics consulting arm for pharma and device manufacturers. Direct head-to-head competitor for HEOR studies, AMCP dossiers, and payer strategy work.

Broad incumbents

• IQVIA: Global life sciences services leader with extensive real-world data assets, HEOR, and market access consulting practices. Competes with Magnolia for strategic engagements while offering a far larger data, technology, and geographic footprint.
• ZS Associates: Global management consultancy with a dedicated market access and patient-centered outcomes practice serving pharma and medtech. Competes for pricing, access, and HEOR engagements, particularly on larger global accounts.
• EVERSANA: Large commercial services firm offering integrated market access, HEOR, patient services, and data analytics to biopharma. Comparable in service mix to Magnolia but at significantly greater scale and with broader global delivery.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/MagnoliaAccess

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Magnolia Market Access